Table 1 Distribution of age, gender and positivity for immunohistochemical biomarkers
|  | All (n = 155) | CRC (n = 83) | CCC (n = 29) | EGJ (n = 15) | PDAC (n = 13) | HCC (n = 4) | Others (n = 11) |
|---|---|---|---|---|---|---|---|
Age [yrs] | Â | Â | Â | Â | Â | Â | Â |
Median (Range) | 61 (24–90) | 60 (25–90) | 63 (38–78) | 58 (24–84) | 62 (39–82) | 58 (49–64) | 63 (32–81) |
Gender, n [%] | Â | Â | Â | Â | Â | Â | Â |
Male | 98 [63%] | 45 [54%] | 20 [69%] | 13 [87%] | 7 [54%] | 4 [100%] | 9 [82%] |
Female | 57 [37%] | 38 [46%] | 9 [31%] | 2 [13%] | 6 [46%] | 0 | 2 [18%] |
Mismatch repair status, n [%] | Â | Â | Â | Â | Â | Â | Â |
pMMR | 121 [78%] | 74 [89%] | 21 [73%] | 13 [87%] | 7 [54%] | 0 | 6 [55%] |
dMMR | 7 [5%] | 5 [6%] | 1 [3%] | 0 | 0 | 0 | 1 [9%] |
ND | 27 [17%] | 4 [5%] | 7 [24%] | 2 [13%] | 6 [46%] | 4 [100%] | 4 [36%] |
Her2-status, n [%] | Â | Â | Â | Â | Â | Â | Â |
Her2-negative | 55 [36%] | 22 [27%] | 13 [45%] | 13 [87%] | 3 [23%] | 0 | 4 [36%] |
Her2-positive | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ND | 100 [64%] | 61 [73%] | 16 [55%] | 2 [13%] | 10 [77%] | 4 [100%] | 7 [64%] |